Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, Chief Invest & Strategy | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 137,231 |
Ending reported balance
After 2026-06-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-01 · Grant · Acquired 63,888 · Balance 145,234 F1: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan. Row 2 · 2026-06-01 · Tax withholding · Disposed 8,003 · Balance 137,231 F2: Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.
F2: Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 8,003 | $21.54 | $172,384.62 |
DisclosureSEC source: 0001193125-26-255704 · ownership.xml · nonDerivative · entry 2 Neeb Don Gregory · CIK 0002079487 · EVP, Chief Invest & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,231 F2 · kind: Represents 8,003 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 63,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-255704 · ownership.xml · nonDerivative · entry 1 Neeb Don Gregory · CIK 0002079487 · EVP, Chief Invest & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,234 F1 · kind: Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantPerformance Share Unit · Derivative | 320,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-103206 · ownership.xml · derivative · entry 2 Neeb Don Gregory · CIK 0002079487 · EVP, Chief Invest & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date. F2 · derivative.exercise_date: Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date. F2 · derivative.expiration_date: Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 81,346 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-103206 · ownership.xml · nonDerivative · entry 1 Neeb Don Gregory · CIK 0002079487 · EVP, Chief Invest & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,346 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.